Click for best price
Cell Gene Therapy Drug Delivery Devices Market Size, Share 2022
Market Analysis and Insights: Global Cell Gene Therapy Drug Delivery Devices Market
The global Cell Gene Therapy Drug Delivery Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Gene Therapy Drug Delivery Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Gene Therapy Drug Delivery Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Gene Therapy Drug Delivery Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Gene Therapy Drug Delivery Devices market.
Global Cell Gene Therapy Drug Delivery Devices Scope and Market Size
Cell and Gene Therapy Drug Delivery Devices market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Sterile Insulin Syringe
Pre-Filled Syringe
Infusion Bags
Segment by Application
Luxturna
Kymriah
Provenge
Zolgensma
Yescarta
Strimvelis
By Company
Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Cell Gene Therapy Drug Delivery Devices product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Cell Gene Therapy Drug Delivery Devices, with price, sales, revenue, and global market share of Cell Gene Therapy Drug Delivery Devices from 2019 to 2022.
Chapter 3, the Cell Gene Therapy Drug Delivery Devices competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cell Gene Therapy Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Cell Gene Therapy Drug Delivery Devices market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Gene Therapy Drug Delivery Devices.
Chapter 13, 14, and 15, to describe Cell Gene Therapy Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Cell Gene Therapy Drug Delivery Devices Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Cell and Gene Therapy Drug Delivery Devices Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sterile Insulin Syringe
1.2.3 Pre-Filled Syringe
1.2.4 Infusion Bags
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Luxturna
1.3.3 Kymriah
1.3.4 Provenge
1.3.5 Zolgensma
1.3.6 Yescarta
1.3.7 Strimvelis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2017-2028)
2.2 Cell and Gene Therapy Drug Delivery Devices Growth Trends by Region
2.2.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Region (2017-2022)
2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2023-2028)
2.3 Cell and Gene Therapy Drug Delivery Devices Market Dynamics
2.3.1 Cell and Gene Therapy Drug Delivery Devices Industry Trends
2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers
2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges
2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2017-2022)
3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2017-2022)
3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue
3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2021
3.5 Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type
4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2017-2022)
4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2023-2028)
5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application
5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2017-2022)
5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
6.2.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
6.2.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
6.2.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
6.3.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
6.3.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
6.4.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
6.4.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type
7.2.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
7.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
7.2.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application
7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
7.3.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
7.3.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country
7.4.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
7.4.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
9.2.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
9.2.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
9.3.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
9.3.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
9.4.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen, Inc.
11.1.1 Amgen, Inc. Company Details
11.1.2 Amgen, Inc. Business Overview
11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.1.5 Amgen, Inc. Recent Developments
11.2 Bausch and Lomb Incorporated
11.2.1 Bausch and Lomb Incorporated Company Details
11.2.2 Bausch and Lomb Incorporated Business Overview
11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction
11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.2.5 Bausch and Lomb Incorporated Recent Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction
11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.3.5 Becton, Dickinson and Company Recent Developments
11.4 Bluebird bio, Inc.
11.4.1 Bluebird bio, Inc. Company Details
11.4.2 Bluebird bio, Inc. Business Overview
11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.4.5 Bluebird bio, Inc. Recent Developments
11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction
11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
11.6 Dendreon Pharmaceuticals LLC.
11.6.1 Dendreon Pharmaceuticals LLC. Company Details
11.6.2 Dendreon Pharmaceuticals LLC. Business Overview
11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction
11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.6.5 Dendreon Pharmaceuticals LLC. Recent Developments
11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction
11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
11.8 Human Stem Cell Institute
11.8.1 Human Stem Cell Institute Company Details
11.8.2 Human Stem Cell Institute Business Overview
11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction
11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.8.5 Human Stem Cell Institute Recent Developments
11.9 Kite Pharma, Inc.
11.9.1 Kite Pharma, Inc. Company Details
11.9.2 Kite Pharma, Inc. Business Overview
11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.9.5 Kite Pharma, Inc. Recent Developments
11.10 Kolon Tissue Gene, inc.
11.10.1 Kolon Tissue Gene, inc. Company Details
11.10.2 Kolon Tissue Gene, inc. Business Overview
11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.10.5 Kolon Tissue Gene, inc. Recent Developments
11.11 Novartis AG
11.11.1 Novartis AG Company Details
11.11.2 Novartis AG Business Overview
11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction
11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.11.5 Novartis AG Recent Developments
11.12 Orchard Therapeutics plc.
11.12.1 Orchard Therapeutics plc. Company Details
11.12.2 Orchard Therapeutics plc. Business Overview
11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.12.5 Orchard Therapeutics plc. Recent Developments
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Details
11.13.2 Pfizer, Inc. Business Overview
11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.13.5 Pfizer, Inc. Recent Developments
11.14 Renova Therapeutics
11.14.1 Renova Therapeutics Company Details
11.14.2 Renova Therapeutics Business Overview
11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction
11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.14.5 Renova Therapeutics Recent Developments
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Details
11.15.2 Spark Therapeutics, Inc. Business Overview
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.15.5 Spark Therapeutics, Inc. Recent Developments
11.16 uniQure N.V.
11.16.1 uniQure N.V. Company Details
11.16.2 uniQure N.V. Business Overview
11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction
11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.16.5 uniQure N.V. Recent Developments
11.17 Vericel Corporation
11.17.1 Vericel Corporation Company Details
11.17.2 Vericel Corporation Business Overview
11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction
11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.17.5 Vericel Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Sterile Insulin Syringe
Table 3. Key Players of Pre-Filled Syringe
Table 4. Key Players of Infusion Bags
Table 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2017-2022)
Table 9. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2023-2028)
Table 11. Cell and Gene Therapy Drug Delivery Devices Market Trends
Table 12. Cell and Gene Therapy Drug Delivery Devices Market Drivers
Table 13. Cell and Gene Therapy Drug Delivery Devices Market Challenges
Table 14. Cell and Gene Therapy Drug Delivery Devices Market Restraints
Table 15. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players (2017-2022)
Table 17. Global Top Cell and Gene Therapy Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2021)
Table 18. Ranking of Global Top Cell and Gene Therapy Drug Delivery Devices Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service
Table 22. Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2017-2022)
Table 26. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2023-2028)
Table 28. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Application (2017-2022)
Table 30. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Application (2023-2028)
Table 32. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028) & (US$ Million)
Table 62. Amgen, Inc. Company Details
Table 63. Amgen, Inc. Business Overview
Table 64. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product
Table 65. Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 66. Amgen, Inc. Recent Developments
Table 67. Bausch and Lomb Incorporated Company Details
Table 68. Bausch and Lomb Incorporated Business Overview
Table 69. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product
Table 70. Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 71. Bausch and Lomb Incorporated Recent Developments
Table 72. Becton, Dickinson and Company Company Details
Table 73. Becton, Dickinson and Company Business Overview
Table 74. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product
Table 75. Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 76. Becton, Dickinson and Company Recent Developments
Table 77. Bluebird bio, Inc. Company Details
Table 78. Bluebird bio, Inc. Business Overview
Table 79. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product
Table 80. Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 81. Bluebird bio, Inc. Recent Developments
Table 82. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
Table 83. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
Table 84. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product
Table 85. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 86. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
Table 87. Dendreon Pharmaceuticals LLC. Company Details
Table 88. Dendreon Pharmaceuticals LLC. Business Overview
Table 89. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product
Table 90. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 91. Dendreon Pharmaceuticals LLC. Recent Developments
Table 92. Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
Table 93. Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
Table 94. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product
Table 95. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 96. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
Table 97. Human Stem Cell Institute Company Details
Table 98. Human Stem Cell Institute Business Overview
Table 99. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product
Table 100. Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 101. Human Stem Cell Institute Recent Developments
Table 102. Kite Pharma, Inc. Company Details
Table 103. Kite Pharma, Inc. Business Overview
Table 104. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product
Table 105. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 106. Kite Pharma, Inc. Recent Developments
Table 107. Kolon Tissue Gene, inc. Company Details
Table 108. Kolon Tissue Gene, inc. Business Overview
Table 109. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product
Table 110. Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 111. Kolon Tissue Gene, inc. Recent Developments
Table 112. Novartis AG Company Details
Table 113. Novartis AG Business Overview
Table 114. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product
Table 115. Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 116. Novartis AG Recent Developments
Table 117. Orchard Therapeutics plc. Company Details
Table 118. Orchard Therapeutics plc. Business Overview
Table 119. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product
Table 120. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 121. Orchard Therapeutics plc. Recent Developments
Table 122. Pfizer, Inc. Company Details
Table 123. Pfizer, Inc. Business Overview
Table 124. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product
Table 125. Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 126. Pfizer, Inc. Recent Developments
Table 127. Renova Therapeutics Company Details
Table 128. Renova Therapeutics Business Overview
Table 129. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product
Table 130. Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 131. Renova Therapeutics Recent Developments
Table 132. Spark Therapeutics, Inc. Company Details
Table 133. Spark Therapeutics, Inc. Business Overview
Table 134. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product
Table 135. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 136. Spark Therapeutics, Inc. Recent Developments
Table 137. uniQure N.V. Company Details
Table 138. uniQure N.V. Business Overview
Table 139. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product
Table 140. uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 141. uniQure N.V. Recent Developments
Table 142. Vericel Corporation Company Details
Table 143. Vericel Corporation Business Overview
Table 144. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product
Table 145. Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 146. Vericel Corporation Recent Developments
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Type: 2021 VS 2028
Figure 2. Sterile Insulin Syringe Features
Figure 3. Pre-Filled Syringe Features
Figure 4. Infusion Bags Features
Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2021 VS 2028
Figure 6. Luxturna Case Studies
Figure 7. Kymriah Case Studies
Figure 8. Provenge Case Studies
Figure 9. Zolgensma Case Studies
Figure 10. Yescarta Case Studies
Figure 11. Strimvelis Case Studies
Figure 12. Cell and Gene Therapy Drug Delivery Devices Report Years Considered
Figure 13. Global Cell and Gene Therapy Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Cell and Gene Therapy Drug Delivery Devices Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region: 2021 VS 2028
Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players in 2021
Figure 17. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2021
Figure 19. North America Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)
Figure 21. North America Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)
Figure 22. North America Cell and Gene Therapy Drug Delivery Devices Market Size Share by Country (2017-2028)
Figure 23. United States Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)
Figure 27. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)
Figure 28. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Share by Country (2017-2028)
Figure 29. Germany Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Share by Region (2017-2028)
Figure 39. China Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Share by Country (2017-2028)
Figure 49. Mexico Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size Share by Country (2017-2028)
Figure 55. Turkey Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Amgen, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 59. Bausch and Lomb Incorporated Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 60. Becton, Dickinson and Company Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 61. Bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 62. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 63. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 64. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 65. Human Stem Cell Institute Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 66. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 67. Kolon Tissue Gene, inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 68. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 69. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 70. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 71. Renova Therapeutics Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 72. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 73. uniQure N.V. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 74. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
